(Q27640499)

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

English

Solution structure of the chick TGFbeta type II receptor ligand-binding domain

scientific article (publication date: 28 February 2003)

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Solution structure of the chick TGFbeta type II receptor ligand-binding domain (English)

0 references

1 reference

based on heuristic

inferred from title

solution structure

1 reference

based on heuristic

inferred from title

author name string

Michael S Marlow

1

0 references

Christopher B Brown

2

0 references

Joey V Barnett

3

0 references

Andrzej M Krezel

4

0 references

language of work or name

0 references

publication date

28 February 2003

0 references

Journal of Molecular Biology

0 references

326

0 references

4

0 references

989-97

0 references

TGF-beta signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

Transforming growth factor-beta induces formation of a dithiothreitol-resistant type I/Type II receptor complex in live cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

TGF beta signals through a heteromeric protein kinase receptor complex

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

Mechanism of activation of the TGF-beta receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

Transforming growth factor-beta and breast cancer: Cell cycle arrest by transforming growth factor-beta and its disruption in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

The transforming growth factor-betas: structure, signaling, and roles in nervous system development and functions

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

Regulation of immune responses by TGF-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

TGFbeta signaling in growth control, cancer, and heritable disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

Invasion and metastasis of a mammary tumor involves TGF-beta signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

The 1.1 A crystal structure of human TGF-beta type II receptor ligand binding domain

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

Three-finger toxin fold for the extracellular ligand-binding domain of the type II activin receptor serine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

Crystal structure of the BMP-2-BRIA ectodomain complex

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

Cloning and developmental expression of the chick type II and type III TGF beta receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

Snake venom alpha-neurotoxins and other 'three-finger' proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

Serine/threonine kinase receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

Identification of a binding site on the type II activin receptor for activin and inhibin

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

Mapping of putative binding sites on the ectodomain of the type II TGF-beta receptor by scanning-deletion mutagenesis and knowledge-based modeling.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

Transforming growth factor beta 1: three-dimensional structure in solution and comparison with the X-ray structure of transforming growth factor beta 2

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

The crystal structure of TGF-beta 3 and comparison to TGF-beta 2: implications for receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

Crystal structure of human bone morphogenetic protein-2 at 2.7 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

Principles of protein-protein interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

1H, 13C, and 15N backbone assignments of the ligand binding domain of TGFbeta type II receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

The program XEASY for computer-supported NMR spectral analysis of biological macromolecules

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

Torsion angle dynamics for NMR structure calculation with the new program DYANA

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

Solution conformation of proteinase inhibitor IIA from bull seminal plasma by 1H nuclear magnetic resonance and distance geometry

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

Three-dimensional solution structure of Escherichia coli periplasmic cyclophilin

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

Protein backbone angle restraints from searching a database for chemical shift and sequence homology

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

Generalized born models of macromolecular solvation effects

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

Comparison of protein solution structures refined by molecular dynamics simulation in vacuum, with a generalized Born model, and with explicit water

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2803%2900023-8

7 January 2021

Identifiers

10.1016/S0022-2836(03)00023-8

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27640499&oldid=1373893464"